76 related articles for article (PubMed ID: 2242115)
1. Calcium leucovorin and 5-fluorouridine cytotoxicity.
Berger SH; Hakala MT
J S C Med Assoc; 1990 May; 86(5):284-9. PubMed ID: 2242115
[TBL] [Abstract][Full Text] [Related]
2. RNA-directed actions of 5-fluorouridine in hemin stimulated K-562 erythroleukemia cells.
Heimer R; Sartorelli AC
Cancer Biochem Biophys; 1992 May; 12(4):221-39. PubMed ID: 1423209
[TBL] [Abstract][Full Text] [Related]
3. Relationship of dUMP and free FdUMP pools to inhibition of thymidylate synthase by 5-fluorouracil.
Berger SH; Hakala MT
Mol Pharmacol; 1984 Mar; 25(2):303-9. PubMed ID: 6608049
[TBL] [Abstract][Full Text] [Related]
4. Modulation of 5-fluoro-2'-deoxyuridine response by folinic acid in human colonic tumor cell lines: the role of thymidylate synthase.
Davis ST; Berger SH
Mol Pharmacol; 1989 Apr; 35(4):422-7. PubMed ID: 2523018
[TBL] [Abstract][Full Text] [Related]
5. Determinants of cytotoxicity with prolonged exposure to fluorouracil in human colon cancer cells.
Ren Q; Van Groeningen CJ; Hardcastle A; Aherne GW; Geoffroy F; Allegra CJ; Johnston PG; Grem JL
Oncol Res; 1997; 9(2):77-88. PubMed ID: 9167189
[TBL] [Abstract][Full Text] [Related]
6. Effects of leucovorin on idoxuridine cytotoxicity and DNA incorporation.
Greene RF; Collins JM
Cancer Res; 1990 Oct; 50(20):6652-6. PubMed ID: 2208128
[TBL] [Abstract][Full Text] [Related]
7. Thymidylate synthase level as the main predictive parameter for sensitivity to 5-fluorouracil, but not for folate-based thymidylate synthase inhibitors, in 13 nonselected colon cancer cell lines.
van Triest B; Pinedo HM; van Hensbergen Y; Smid K; Telleman F; Schoenmakers PS; van der Wilt CL; van Laar JA; Noordhuis P; Jansen G; Peters GJ
Clin Cancer Res; 1999 Mar; 5(3):643-54. PubMed ID: 10100718
[TBL] [Abstract][Full Text] [Related]
8. In vitro enhancement of fluoropyrimidine-induced cytotoxicity by leucovorin in colorectal and gastric carcinoma cell lines but not in non-small-cell lung carcinoma cell lines.
Sugimoto Y; Ohe Y; Nishio K; Ohmori T; Fujiwara Y; Saijo N
Cancer Chemother Pharmacol; 1992; 30(6):417-22. PubMed ID: 1327567
[TBL] [Abstract][Full Text] [Related]
9. The inhibition of ribosomal RNA synthesis and maturation in Novikoff hepatoma cells by 5-fluorouridine.
Wilkinson DS; Tlsty TD; Hanas RJ
Cancer Res; 1975 Nov; 35(11 Pt 1):3014-20. PubMed ID: 171060
[TBL] [Abstract][Full Text] [Related]
10. Role of folylpolyglutamates in biochemical modulation of fluoropyrimidines by leucovorin.
Romanini A; Lin JT; Niedzwiecki D; Bunni M; Priest DG; Bertino JR
Cancer Res; 1991 Feb; 51(3):789-93. PubMed ID: 1988119
[TBL] [Abstract][Full Text] [Related]
11. Combined modulation by leucovorin and alpha-2a interferon of fluoropyrimidine mediated growth inhibition.
Sinnige HA; Timmer-Bosscha H; Peters GF; De Vries EG; Mulder NH
Anticancer Res; 1993; 13(5A):1335-40. PubMed ID: 8239504
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of the combination therapy of 5-fluorouracil, cisplatin and leucovorin for hepatocellular carcinoma and its predictable factors.
Kogure T; Ueno Y; Iwasaki T; Shimosegawa T
Cancer Chemother Pharmacol; 2004 Apr; 53(4):296-304. PubMed ID: 14689231
[TBL] [Abstract][Full Text] [Related]
13. Effects of D-glucosamine and 6-azauridine on nucleotide contents, 5-fluorouridine uptake, and cytotoxicity in TA3 mammary tumor cells.
Holstege A; Keppler D
J Natl Cancer Inst; 1986 Mar; 76(3):485-92. PubMed ID: 2419623
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of innate resistance to thymidylate synthase inhibition after 5-fluorouracil.
Spears CP; Gustavsson BG; Berne M; Frösing R; Bernstein L; Hayes AA
Cancer Res; 1988 Oct; 48(20):5894-900. PubMed ID: 3167844
[TBL] [Abstract][Full Text] [Related]
15. Biochemical modulation of 5-fluorouracil with or without leucovorin by a low dose of brequinar in MGH-U1 cells.
Chen TL; Erlichman C
Cancer Chemother Pharmacol; 1992; 30(5):370-6. PubMed ID: 1380407
[TBL] [Abstract][Full Text] [Related]
16. The mechanism of 5-fluorouridine toxicity in Novikoff hepatoma cells.
Wilkinson DS; Crumley J
Cancer Res; 1976 Nov; 36(11 Pt 1):4032-8. PubMed ID: 184924
[TBL] [Abstract][Full Text] [Related]
17. Preliminary results of a phase II trial for the treatment of metastatic breast cancer with 5-fluorouracil and leucovorin.
Allegra CJ; Chabner BA; Sholar PW; Bagley C; Drake JC; Lippman ME
NCI Monogr; 1987; (5):199-202. PubMed ID: 3501543
[TBL] [Abstract][Full Text] [Related]
18. Thymidylate synthase as a target for growth inhibition in methotrexate-sensitive and -resistant human head and neck cancer and leukemia cell lines.
McGuire JJ; Magee KJ; Russell CA; Canestrari JM
Oncol Res; 1997; 9(3):139-47. PubMed ID: 9220499
[TBL] [Abstract][Full Text] [Related]
19. Prolonged and enhanced suppression of thymidylate synthase by weekly 24-h infusion of high-dose 5-fluorouracil.
Yeh KH; Yeh SH; Hsu CH; Wang TM; Ma IF; Cheng AL
Br J Cancer; 2000 Dec; 83(11):1510-5. PubMed ID: 11076661
[TBL] [Abstract][Full Text] [Related]
20. Correlation between ribosomal RNA production and RNA-directed fluoropyrimidine cytotoxicity.
Takimoto CH; Tan YY; Cadman EC; Armstrong RD
Biochem Pharmacol; 1987 Oct; 36(19):3243-8. PubMed ID: 2444230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]